Using cannabis while taking an SSRI is not considered safe. Both THC and CBD interfere with the same liver enzymes your body uses to break down most SSRIs, which can raise the levels of the antidepressant in your blood and intensify side effects. There is also a small but real risk of serotonin syndrome, a potentially dangerous reaction. The severity of the interaction depends on which SSRI you take and what type of cannabis product you use.
How Cannabis Changes SSRI Levels in Your Body
Your liver uses specific enzymes to process SSRIs and clear them from your system. THC and CBD both block two of the most important ones: CYP2C19 and, to a lesser extent, CYP2D6. When these enzymes are inhibited, your body breaks down the SSRI more slowly, and the drug builds up in your bloodstream. Pharmacokinetic models show that CBD and THC increase the blood concentrations of sertraline (Zoloft), citalopram (Celexa), and escitalopram (Lexapro) in particular.
The interaction goes both ways. Sertraline, for example, also inhibits the enzymes that break down THC. So the SSRI makes THC hit harder, and the THC makes the SSRI accumulate. The result is that both substances are more potent than either would be alone, raising the risk of side effects from both.
Which SSRIs Are Most Affected
Not all SSRIs carry the same level of risk. The interaction is strongest with SSRIs processed primarily by CYP2C19:
- Sertraline (Zoloft): high likelihood of interaction with cannabis
- Citalopram (Celexa): high likelihood of interaction
- Escitalopram (Lexapro): high likelihood of interaction
SSRIs processed mainly through CYP2D6 have a somewhat lower, but still present, interaction risk:
- Fluoxetine (Prozac): moderate interaction risk
- Paroxetine (Paxil): moderate interaction risk
- Fluvoxamine (Luvox): moderate interaction risk
CBD appears to block CYP2C19 more strongly than THC does, which means CBD-heavy products may actually pose a greater drug interaction risk with sertraline and escitalopram than THC-dominant ones. This is worth noting because many people assume CBD is the “safer” option.
Side Effects People Have Experienced
Clinical case reviews have documented a range of adverse effects in people who combined cannabis with SSRIs, particularly sertraline. Reported reactions include dizziness, disorientation, headache, blurry vision, rapid heart rate, panic attacks, agitation, hallucinations, dry mouth, and dry eyes. In one case, a 38-year-old woman using sertraline and high-THC cannabis experienced vomiting severe enough to require hospitalization. Another patient, a 61-year-old woman on 150 mg of sertraline, developed a dangerously fast heart rhythm along with panic attacks and disorientation.
These aren’t common reactions to cannabis or SSRIs alone at normal doses. They emerge because each substance amplifies the other. The cannabis boosts the SSRI’s blood level beyond what the prescribed dose was intended to produce, while the SSRI simultaneously boosts the THC concentration.
The Serotonin Syndrome Risk
Serotonin syndrome occurs when too much serotonin activity builds up in the brain and body. Symptoms include agitation, rapid heart rate, high blood pressure, fever, sweating, muscle twitching, and in severe cases, seizures or loss of consciousness. It can be life-threatening.
A case published in Australasian Psychiatry describes a 20-year-old man on fluoxetine (40 mg) who was hospitalized three times in three weeks with serotonin syndrome. On two of those occasions, he had used cannabis products shortly before symptoms began. On one visit, he had taken cannabis oil containing 28.5 mg/mL of THC about one to two hours before becoming feverish, agitated, and unresponsive, with involuntary muscle jerking in his legs. On another, he used a THC vape pen less than three hours before a similar episode. Cannabis products were present on every occasion serotonin syndrome appeared.
This is still considered rare, and that patient had other complicating factors. But the case is consistent with a growing pattern of reports from the United States linking high-concentrate cannabis to serotonin syndrome in people on antidepressants. The risk is likely higher with potent products like concentrates, oils, and vape cartridges compared to lower-THC flower.
CBD Products Are Not a Safe Workaround
CBD is often marketed as a mellow, non-psychoactive alternative, but it actually poses a stronger drug interaction risk with certain SSRIs than THC does. CBD is a potent inhibitor of CYP2C19 and also blocks CYP2D6. Because of this, it can raise blood levels of virtually every SSRI on the market. A comprehensive review in the Journal of General Internal Medicine found that CBD inhibition of these liver enzymes may increase the serum concentrations of SSRIs, tricyclic antidepressants, antipsychotics, and several other drug classes.
This means that even “just taking CBD” for sleep or anxiety while on an SSRI can push your antidepressant levels higher than intended. The same applies to combination products that contain both THC and CBD.
What This Means Practically
If you’re currently using cannabis and starting an SSRI, or you’re on an SSRI and considering trying cannabis, the interaction is real and well-documented. It’s not a guaranteed emergency every time someone combines them, but it is unpredictable. Your individual risk depends on your genetics (some people are already slow metabolizers of these enzymes), your SSRI dose, and the potency and type of cannabis product.
The combination is most concerning with sertraline, citalopram, or escitalopram, because those SSRIs rely heavily on the exact enzyme pathway cannabis blocks. It’s somewhat less risky with fluoxetine or paroxetine, though still not without concern. Higher-potency cannabis products, concentrates, and edibles with large CBD content carry more interaction potential than occasional low-dose use.
If you’re using both and notice new or worsening dizziness, rapid heartbeat, unusual agitation, muscle twitching, or episodes of confusion, those symptoms may reflect a drug interaction rather than anxiety or a “bad high.” That distinction matters, because serotonin-related reactions can escalate quickly and need medical attention.